Atipamezole Impurity 3 | CAS 2581300-47-0 - Request Quote
Atipamezole Impurity 3
| SZ CAT No: | SZ-A176004 |
| CAS No | 2581300-47-0 |
| Mol.F. | C33H30N2O2 |
| Mol.Wt. | 486.6 |
| Inv. Status | Synthesis on demand |
Chemical Name :
Shipping Temperature :
HSN Code :
Country of Origin :
Smiles :
Usage Note:
Atipamezole Impurity 3 is chemically 2-Ethyl-2-(1-trityl-1H-imidazol-4-yl)-2,3-dihydro-1H-indene-1,3-diol. Atipamezole Impurity 3 is supplied with detailed characterization data compliant with regulatory guideline. Atipamezole Impurity 3 can be used for the analytical method development, method validation (AMV), Quality Controlled (QC) application for Abbreviated New Drug Application (ANDA) or during commercial production of Atipamezole.
The product can be used as reference standards and further traceability against pharmacopeial standards (USP or EP) can be provided based on feasibility. SynZeal products are for analytical purpose only and not for human use.
Applications & Regulatory Use Cases
Buy 2581300-47-0
Purchase 2581300-47-0
Order 2581300-47-0
Enquire 2581300-47-0
price of 2581300-47-0
2581300-47-0 Supplier
2581300-47-0 Manufacturer
2581300-47-0 Exporter
buy high quality Atipamezole Impurity 3
Purchase Atipamezole Impurity 3
Atipamezole Impurity 3 suppliers
Atipamezole Impurity 3 manufacturers
Atipamezole Impurity 3 price
Order Atipamezole Impurity 3
Enquire Atipamezole Impurity 3
Atipamezole Impurity 3 cost
Atipamezole Impurity 3 Supplier
Atipamezole Impurity 3 Distributor
Atipamezole Impurity 3 for Method Validation
Atipamezole Reference Standard
Atipamezole Impurity 3 for ANDA Filing
Atipamezole Impurity 3 for Forced Degradation Studies
Atipamezole Impurity 3 Identification Standards
Atipamezole Impurity 3 for DMF Filing
Related Products
Disclaimer
SynZeal product information given on this website is as per the existing understanding while publishing the details on website. The customer is responsible for assessing the accuracy of the information at the time of actual purchase.
SynZeal will update these details as per new developments or findings in product specifications without further notice.